Agenus Newsroom

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating

Futu News00:32

Agenus Analyst Ratings

BenzingaJan 22 20:38

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating

Futu NewsJan 22 20:34

Agenus (AGEN) Receives a Hold From H.C. Wainwright

TipRanksJan 22 20:21

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Maintains Target Price $11

Futu NewsJan 7 21:31

Promising Potential for Agenus in Oncology: Buy Rating Reinforced by Strong CRC and Gastric Cancer Therapy Prospects

TipRanksJan 7 21:07

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating

Futu NewsDec 6, 2024 01:35

Agenus Analyst Ratings

BenzingaNov 29, 2024 17:44

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating, Maintains Target Price $7

Futu NewsNov 28, 2024 01:31

Cautious Hold Rating on Agenus Amid Strategic Realignment and Financial Challenges

TipRanksNov 28, 2024 01:28

Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Agenus (AGEN) and SAGE Therapeutics (SAGE)

TipRanksNov 25, 2024 14:15

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $11

Futu NewsNov 19, 2024 16:40

B. Riley Adjusts Agenus Price Target to $11 From $18, Maintains Buy Rating

MT NewswiresNov 18, 2024 21:50

Promising Developments and Strategic Financing Enhance Agenus's Buy Rating Amidst Stock Volatility

TipRanksNov 18, 2024 20:47

Agenus Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesNov 13, 2024 00:13

Agenus Analyst Ratings

BenzingaNov 13, 2024 00:06

H.C. Wainwright Maintains Agenus(AGEN.US) With Hold Rating, Cuts Target Price to $7

Futu NewsNov 12, 2024 23:32

Agenus Analyst Ratings

BenzingaAug 14, 2024 21:29

B. Riley Adjusts Price Target on Agenus to $18 From $42, Maintains Buy Rating

MT NewswiresAug 14, 2024 19:59

B.Riley Financial Maintains Agenus(AGEN.US) With Buy Rating, Cuts Target Price to $18

Futu NewsAug 14, 2024 02:31